The Ozempic Effect
A weight loss drug is rewriting grocery aisles, portion sizes, and what ends up in your cart.
The Big Story
Ozempic and Wegovy are changing how people eat. Most people on them eat less, so what they choose matters more.
That’s why you’re seeing smaller portions, more protein, and foods made to keep you full longer.
The Two Spins
From the Left
Helps people manage weight and related health issues more effectively than diet alone.
Companies may profit by promoting expensive products and processed “health” foods alongside them.
From the Right
Gives people another option to manage weight without relying only on strict diet routines.
Long-term reliance on medication may replace sustainable habits like diet and exercise.
What This Means for Us
This is already showing up in how people shop and order food.
You’re seeing more high-protein labels, smaller portions, and meals built to keep you full longer. Because when a large group eats less, companies don’t sell less; they simply change what ends up in your cart.
How They Make Money
Ozempic and Wegovy use the same underlying drug (semaglutide) but are sold for different uses, expanding how many people can be prescribed it.
These prescriptions cost up to $1,300 per month without insurance, creating steady, repeat revenue from long-term use.
Takeaway
One drug, marketed two ways, is driving demand across both healthcare and food industries.
The Number That Stuck With Me
1
About 1 in 8 U.S. adults have tried a GLP-1 drug, enough to shift both healthcare and food demand.